preview

Should Religious Exemptions For Hpv Vaccination Are Allowed By The Law?

Better Essays
Many parents and organizations are opposed to this policy because they feel that it is an infringement on personal choice. While religious exemptions to HPV vaccination are allowed by the law, there is no built in policy for exemptions based on personal secular values. Some vegan families, for example, may feel uncomfortable vaccinating their children since animals are involved in the research and development of several vaccines, including the HPV vaccine. Individuals against animal testing, or recombinant DNA technology (Gardasil (Human Papillomavirus Vaccine) Questions and Answers, 2006) could feel uneasy about the Gardasil vaccine as well (Gardasil 9, 2014). In addition, some fear that this policy will “promot[e] promiscuity” (Marsa,…show more content…
While practitioners can use their best judgement to identify other factors that may put a child at risk for an adverse reaction, there will inevitably be some cases that fall through the cracks simply due to a lack of knowledge. Some people with rare, little understood metabolic conditions—for example—might react unfavorably to an HPV vaccine, resulting in severe side effects (Menni, Chiarelli, Sabatini, Principi, & Esposito, 2012). Merck’s Gardasil 9 prescription manual reported a 1.0% incidence of “vaccine-related adverse experiences”; adverse symptoms included “pyrexia, allergy to vaccine, asthmatic crisis, headache, and tonsillitis” (Gardasil 9, 2014). This raises a difficult ethical dilemma: Is it justifiable to force a typically healthy behavior on a significant portion of a state’s residents, knowing that a small minority can become severely ill as a result? In addition, many would agree that the vaccine has not been tested sufficiently in minority populations in the US. Clinical trials for Gardasil and Gardasil 9, for example, consisted of primarily white participants (Gardasil 9, 2014). Clinical trials for Gardasil included .1% and .3% American Indians in the 9-26 y.o. male and female clinical trial treatment groups respectively. These percentages correspond to about 10 and 30 participants respectively (Gardasil 9,
Get Access